Liver Disease Cirrhosis

Another study confirms detrimental effects of delaying hepatitis C treatment

Another study confirms detrimental effects of delaying hepatitis C treatment Liz Highleyman Produced in collaboration with hivandhepatitis.com Published: 05 May 2015 Deferring antiviral therapy for hepatitis C until a person progresses to advanced liver disease has clear drawbacks including lower treatment effectiveness and an increased risk of clinical events and death, according to a study…

Read More

FAQs about Alcoholic Liver Disease

FAQs about Alcoholic Liver Disease     What is alcoholic liver disease (ALD)? ALDis the development of liver damage as a result of heavy alcohol consumption. This damage may occur in three patterns: fatty liver (an abnormal accumulation of fat in the structural cells of the liver), alcoholic hepatitis (inflammation of the liver caused by…

Read More

Harvoni Is Here: The Once-a-Day, Single Hep C Pill

Interferon-free and ribavirin-free treatment has finally arrived, but someone has to pay for this miracle Hepatitis C pill. The Hepatitis C community has been waiting a long time for a miracle – and Harvoni nearly fits the bill. Approved on October 10, 2014, Harvoni became the first Hepatitis C drug approved by the U.S. Food…

Read More

Hepatitis C Epidemic in Africa

Hepatitis C Epidemic in Africa The epidemic levels of Hepatitis C virus (HCV) prevalence in Africa is considered one of the most serious health challenges facing African nations by the World Health Organization (WHO). According to Dr. Peter Beyer, Essential Medicines Advisor at WHO, the greatest challenges to fighting HCV in Africa are drug access…

Read More

7 Ways Hepatitis C Affects Women Differently than Men

7 Ways Hepatitis C Affects Women Differently than Men Although the virus itself does not discriminate against gender, these seven differences between men and women with Hepatitis C are worth reviewing. First discovered as a contagious virus in 1989, Hepatitis C currently infects an estimated four million Americans. While this highly transmissible virus does not…

Read More

NCKU team discovers new liver disease treatment

NCKU team discovers new liver disease treatment TAIPEI, Taiwan — A National Cheng Kung University (NCKU) team has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis and recover liver function, according to a press release from the school. Ming-shi Chang, chair professor of biochemistry and molecular biology…

Read More

Understanding the strains of hepatitis

Understanding the strains of hepatitis by Cedric Ricks Enlarge Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University. Hepatitis C is a very sneaky creature that coats itself in an envelope which changes every time the body tries…

Read More

Observing National Hepatitis Testing Day

Observing National Hepatitis Testing Day Dr. Ronald Valdiserri Next Monday, May 19th, is the third national Hepatitis Testing Day, established to raise greater awareness of an epidemic that is too often unrecognized. Millions Living with Undiagnosed Infections There are approximately 3.5–5.3 million Americans living with chronic viral hepatitis, but most of them do not know…

Read More

Medicare Eases Restrictions On Pricey Hepatitis C Treatment

Medicare Eases Restrictions On Pricey Hepatitis C Treatment By Richard Knox Alexandra Olgin for NPR This policy change would pay for treatment with a combination of new, expensive drugs for patients who haven’t responded to older treatment regimens and are approaching or have cirrhosis of the liver. Friday, May 16, 2014 Federal Medicare officials are…

Read More